Results 51 to 60 of about 1,762,260 (306)

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang   +4 more
wiley   +1 more source

Global and Regional Temporal Changes in Cross‐Country Inequalities of Site‐Specific Osteoarthritis Burden, 1990 to 2021

open access: yesArthritis Care &Research, EarlyView.
Objective This study examined the global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis (OA) burden from 1990 to 2021. Methods Age‐standardized years lived with disability rates (ASYRs) for site‐specific OA across 204 countries and territories were obtained from the Global Burden of Diseases, Injuries, and ...
Haowei Chen   +14 more
wiley   +1 more source

STATE POLICY OF INNOVATION

open access: yesСравнительная политика, 2015
State policy of innovation.
A. M. Ignatova
doaj   +1 more source

DID model based research on the policy effect of national independent innovative demonstration zones [PDF]

open access: yesSHS Web of Conferences, 2019
National Independent Innovation Demonstration Zone set up as combination of regional technology innovation policy in nine areas of Beijing Zhongguancun, East Lake in Wuhan, Shanghai Zhangjiang as a national independent innovation demonstration area as a ...
Wang Xinyu, Ma Yu
doaj   +1 more source

Competition Policy and Innovation [PDF]

open access: yes
L'article analyse les complémentarités et les tensions entre la concurrence et l'innovation tant du point de vue des instruments d'analyse que du point de vue des politiques économiques.competition for the market; patent thicket ...
Carl Shapiro
core   +3 more sources

Economic Burden of Rheumatoid Arthritis in Low‐ and Middle‐Income Countries: Systematic Review and Meta‐Analysis

open access: yesArthritis Care &Research, EarlyView.
Objective The aim of this systematic review was to synthesize the economic impact of rheumatoid arthritis (RA) on households, health systems, and society in low‐ and middle‐income countries (LMICs). Methods Electronic databases such as PubMed, Web of Science, and CINAHL were searched using keywords related to RA and cost of illness.
Tadesse Gebrye   +6 more
wiley   +1 more source

Local Knowledge and Innovation Policy [PDF]

open access: yesEnvironment and Planning C: Government and Policy, 2007
Innovation policy has become a key issue in many countries. There is also growing awareness that one of the foundation stones of an effective innovation strategy is formed by a professional and advanced local knowledge infrastructure (see, eg, Jaffe et al, 1993; Saviotti and Nooteboom, 2000).
Noronha, Teresa de   +2 more
openaire   +3 more sources

Evolution of the Polish Innovation Policy [PDF]

open access: yes, 2009
The innovation policy realized at present in Poland seems to be convergent with the assumptions of the EU- documents and OECD- reports. Nevertheless, numerous problems still require a solution.
Dworak, Edyta
core   +2 more sources

Physician Referral Patterns to Physical Therapists for Managing Knee Osteoarthritis: A Retrospective Analysis of Electronic Health Records From an Integrated Health System

open access: yesArthritis Care &Research, EarlyView.
Objective This study aims to describe the frequency and timing of physician referrals to physical therapists (PTs) and other treatments prescribed over 12 months in patients with recent onset of knee osteoarthritis (KOA). The study also aims to identify determinants of early PT referrals.
Samannaaz S. Khoja   +4 more
wiley   +1 more source

Cost‐Effectiveness of Low‐Dose Colchicine Prophylaxis When Starting Allopurinol Using the “Start‐Low Go‐Slow” Approach for Gout: Evidence From a Noninferiority Randomized Double‐Blind Placebo‐Controlled Trial

open access: yesArthritis Care &Research, EarlyView.
Objective The aim of this study was to investigate the cost‐effectiveness of low‐dose colchicine prophylaxis for preventing gout flares when starting allopurinol using the “start‐low go‐slow” approach. Methods Participants with gout, fulfilling the American College of Rheumatology recommendations for starting urate‐lowering therapy and with serum urate
Yana Pryymachenko   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy